Drug Safety

More formal, open-label study expected to net better data

Increased rate of depression reported in children exposed to oxycodone and codeine in breast milk

Slowly but surely, things are falling into place to allow pharmacists to take advantage of regulated techs.

New developments in therapy, vitamin D requirements, bisphosphonate safety and risk assessment.

Regulation of herbal products has been a long time coming, but will it change anything?

Sanofi-Aventis has discontinued further development of rimonabant for all therapeutic indications.

Overdose with venlafaxine may be associated with a higher risk of fatal outcome compared to overdose with selective serotonin reuptake inhibitor antidepressants, but lower than that seen with tricyclic antidepressants.